Literature DB >> 19013796

Molecular modeling of the alpha9alpha10 nicotinic acetylcholine receptor subtype.

Edwin G Pérez1, Bruce K Cassels, Gerald Zapata-Torres.   

Abstract

This study reports the comparative molecular modeling, docking and dynamic simulations of human alpha9alpha10 nicotinic acetylcholine receptors complexed with acetylcholine, nicotine and alpha-conotoxin RgIA, using as templates the crystal structures of Aplysia californica and Lymnaea stagnalis acetylcholine binding proteins. The molecular dynamics simulations showed that Arg112 in the complementary alpha10(-) subunit, is a determinant for recognition in the site that binds small ligands. However, Glu195 in the principal alpha9(+), and Asp114 in the complementary alpha10(-) subunit, might confer the potency and selectivity to alpha-conotoxin RgIA when interacting with Arg7 and Arg9 of this ligand.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013796     DOI: 10.1016/j.bmcl.2008.10.094

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA.

Authors:  Layla Azam; J Michael McIntosh
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

2.  Computational modeling study of human nicotinic acetylcholine receptor for developing new drugs in the treatment of alcoholism.

Authors:  Zeng-Jian Hu; Li Bai; Yousef Tizabi; William Southerland
Journal:  Interdiscip Sci       Date:  2009-11-14       Impact factor: 2.233

3.  Molecular interaction of α-conotoxin RgIA with the rat α9α10 nicotinic acetylcholine receptor.

Authors:  Layla Azam; Athanasios Papakyriakou; Marios Zouridakis; Petros Giastas; Socrates J Tzartos; J Michael McIntosh
Journal:  Mol Pharmacol       Date:  2015-03-04       Impact factor: 4.436

4.  GABA binding to an insect GABA receptor: a molecular dynamics and mutagenesis study.

Authors:  Jamie A Ashby; Ian V McGonigle; Kerry L Price; Netta Cohen; Federico Comitani; Dennis A Dougherty; Carla Molteni; Sarah C R Lummis
Journal:  Biophys J       Date:  2012-11-20       Impact factor: 4.033

5.  Functional characterization of alpha9-containing cholinergic nicotinic receptors in the rat adrenal medulla: implication in stress-induced functional plasticity.

Authors:  Claude Colomer; Luis A Olivos-Oré; Anne Vincent; J Michael McIntosh; Antonio R Artalejo; Nathalie C Guérineau
Journal:  J Neurosci       Date:  2010-05-12       Impact factor: 6.167

6.  Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1.

Authors:  Dinesh C Indurthi; Elena Pera; Hye-Lim Kim; Cindy Chu; Malcolm D McLeod; J Michael McIntosh; Nathan L Absalom; Mary Chebib
Journal:  Biochem Pharmacol       Date:  2014-02-15       Impact factor: 5.858

Review 7.  Alpha9 nicotinic acetylcholine receptors and the treatment of pain.

Authors:  J Michael McIntosh; Nathan Absalom; Mary Chebib; Ana Belén Elgoyhen; Michelle Vincler
Journal:  Biochem Pharmacol       Date:  2009-05-27       Impact factor: 5.858

8.  Blockade of neuronal α7-nAChR by α-conotoxin ImI explained by computational scanning and energy calculations.

Authors:  Rilei Yu; David J Craik; Quentin Kaas
Journal:  PLoS Comput Biol       Date:  2011-03-03       Impact factor: 4.475

Review 9.  Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads.

Authors:  Christopher J Armishaw
Journal:  Toxins (Basel)       Date:  2010-06-14       Impact factor: 4.546

Review 10.  Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?

Authors:  Sarasa A Mohammadi; MacDonald J Christie
Journal:  Toxins (Basel)       Date:  2015-09-28       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.